FDA Approves New Combination for BRAF V600E-Mutated Colorectal Cancer
The U.S. Food and Drug Administration (FDA) approved Braftovi® (encorafenib) in combination with cetuximab for previously treated patients with metastatic colorectal cancer (CRC) with...
Patients With Polyps More Likely to Have Colorectal Cancer
A matched cohort study found that patients with any polyps have a greater likelihood of having colorectal cancer, and those with sessile serrated polyps,...
The Density of Immune Cells May be Used to Predict Survival in Patients with...
The density of immune cells in conjunction with tumor budding analysis may serve as a viable option for accurately predicting survival in patients with...
Patients who Undergo Bariatric Surgery Have a Lower Risk of Developing Colorectal Cancer
Patients who undergo bariatric surgery have a 35% less risk of developing colorectal cancer compared with obese individuals who had no surgery, according to...
Is This Bacteria the Cause for the Increase in Colorectal Cancer Cases in Younger...
A study found that the oral bacterium Fusobacterium nucleatum (F. nuc) presents in a greater number of colorectal cancer (CRC) tumors among younger patients (diagnosed...
U.S. Cancer Mortality Rate Has Significant Single-Year Drop
The U.S. cancer mortality rate has continued to decline for the 26th year in a row, according to data from the American Cancer Society...
Aspirin Curbs Colorectal Cancer Reoccurrence
The use of aspirin appears to reduce tumor growth and inhibit colorectal cancer recurrence, according to the findings of a study conducted by City...
